Skip to content

A clinical study comparing two ayurvedic medicines aragawadha kapila avaleha and haritaki pippali avaleha for treating constipation in children age 3 to 6 years

A Randomized Comparative Clinical trial to evaluate the efficacy of Aragwadha Kapila Avaleha and Haritaki Pippali Avaleha in the management of childhood constipation among pre school children aged 3 to 6 years. - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/04/108648
Enrollment
33
Registered
2026-04-20
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K929- Disease of digestive system, unspecified

Interventions

None listed

Sponsors

PDEAs college of ayurveda and research centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Diagnosed with functional constipation as per standard clinical or ROME IV CRITERIA 2) Straining during more than 25% of defecations. 3) Lumpy or hard stools (Bristol stool Scale 1-2) more than 25% defecations. 4) Sensation of incomplete evacuation more than 25% defecations. 5)Presence of a large fecal mass in the colon 6) History of large diameter stools which may obstruct the toilet. 7) Associated symptoms- Abdominal pain, Anorexia.

Exclusion criteria

Exclusion criteria: 1.Constipation due to organic or structural causes - Hirschsprug s disease, piles. 2.Known case of cerebral palsy or constipation due to any other neuromuscular disorder. 3. Known case of hypothyroidism, Irritable Bowel Syndrome. 4.Children with severe abdominal pain. 5.Children with known case of any food allergy.

Design outcomes

Primary

MeasureTime frame
To compare the efficacy of Aaragwadha Kapila Avaleha and Haritaki Pippali Avaleha in relieving constipation, measured by improvement in regulation in stool frequency and consistency, in preschool children aged 3 to 6 years over 14 days.Timepoint: 14 days of study with follow up on 3rd, 7th, 14th day.

Secondary

MeasureTime frame
To observe the adverse effects of the drug if any.Timepoint: 14 days of study with follow up on 3rd, 7th, 14th day.

Countries

India

Contacts

Public ContactDr Madhavi Deodas

PDEAs College of Ayurved and Research Centre,Nigdi ,Pune

drdeodasms@gmail.com94230108181

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026